← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 1, 2009Last known activity
Oct 20, 2021
Acquired by Celerion on Jan 11, 2016
Timeline
2000s
- Jun 1, 2002
Assign Clinical Research GmbH— Founded
2010s
- Jan 11, 2016
Celerion— Acquired By
Drugs by trial phase (19 distinct, 11 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (12 own, 0 via acquisition)
Indications
Studied for
- Anemia, Hemolytic
- Anemia, Hemolytic, Autoimmune
- Carcinoma
- Carcinoma, Neuroendocrine
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Squamous Cell
- Chikungunya Fever
- Colorectal Neoplasms
- Disease Progression
- Esophageal Squamous Cell Carcinoma
- Gastrointestinal Neoplasms
- Infections
- Kidney Failure, Chronic
- Lassa Fever
- Multiple Myeloma
- Neoplasms, Plasma Cell
- Neoplasms, Squamous Cell
- Neuroendocrine Tumors
- Pemphigoid, Bullous
- Sarcoma
- Virus Diseases
Recent trials (11)
- NCT04891809CollaboratorPhase 2Oct 20, 2021
- NCT04195373CollaboratorPhase 1/Phase 2Apr 30, 2020
- NCT04055454CollaboratorPhase 1Sep 30, 2019
- NCT03792763CollaboratorPhase 2Jun 30, 2019
- NCT02861586CollaboratorPhase 2Aug 1, 2016
- NCT02113800CollaboratorPhase 2Aug 1, 2015
- NCT02502903CollaboratorPhase 1Jun 1, 2015
- NCT02331927CollaboratorPhase 2Mar 1, 2015
- NCT01627379CollaboratorPhase 3May 1, 2012
- NCT01326767CollaboratorPhase 3Mar 1, 2011
- NCT01259518CollaboratorPhase 1Nov 1, 2009
Details
- Founded
- Vienna, AT Jun 1, 2002
- Last known activity
- Oct 20, 2021
Notes
CRO